 |
 |

Antidepressants and the Risk of Suicidal Behaviors
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Jick and colleagues1 reported that the risk of suicidal behavior after initiating antidepressant treatment is similar among users of amitriptyline, fluoxetine, and paroxetine compared with the risk among users of dothiepin. This finding is relevant in countries where dothiepin is a reference antidepressant, such as the United Kingdom, but is less helpful where this agent has never been licensed, such as Italy and the United States.
In these and other countries, amitriptyline and other nondothiepin tricyclic antidepressants had been considered the standard treatment for depression, both in clinical practice and in experimental studies.2 Newer antidepressants are now available, and a crucial question is whether suicidal behavior is increased in users of selective serotonin reuptake inhibitors compared with users of amitriptyline or other reference tricyclic antidepressants. Although Jick and colleagues did not address this issue, Table 3 in their article raises a question of a difference between . . . [Full Text of this Article]
Corrado Barbui, MD
corrado.barbui@univr.it Department of Medicine and Public Health Section of Psychiatry and Clinical Psychology University of Verona Verona, Italy
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Antidepressants and the Risk of Suicidal Behaviors
Iradj Maany
JAMA. 2004;292(23):2833.
EXTRACT
| FULL TEXT
Antidepressants and the Risk of Suicidal BehaviorsReply
Hershel Jick, James A. Kaye, and Susan S. Jick
JAMA. 2004;292(23):2833.
EXTRACT
| FULL TEXT
Antidepressants and the Risk of Suicidal Behaviors
Hershel Jick, James A. Kaye, and Susan S. Jick
JAMA. 2004;292(3):338-343.
ABSTRACT
| FULL TEXT
|